Baxter Initiates Worldwide Voluntary Recall - - BioPharm International

ADVERTISEMENT

Baxter Initiates Worldwide Voluntary Recall



Baxter International has initiated a voluntary recall to the hospital/user level of one lot of 5% dextrose injection, USP and four lots of 0.9% sodium chloride injection, USP due to particulate matter found in the solutions. There have been no reported adverse events associated with this issue to date, and the root cause of this recall has been identified and resolved.

Products affected by this recall were packaged in flexible plastic containers with 96 containers per carton. Affected product was distributed to healthcare centers and distributors in Saudi Arabia, Singapore, United Arab Emirates, and the United States and Puerto Rico.

Baxter has notified customers, who are being directed not to use product from the recalled lots. Customers that have product affected by this recall should stop use and arrange for return. The affected lots were distributed to customers between May 2012 and October 2013.

Source: Baxter International

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

First Biosimilar Application Kicks Off Legal Battle
October 31, 2014
FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Author Guidelines

Click here